Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome. [electronic resource]
- Expert opinion on therapeutic targets Mar 2017
- 333-348 p. digital
Publication Type: Journal Article; Review
1744-7631
10.1080/14728222.2017.1280467 doi
Animals Carbohydrate Metabolism--physiology Drug Design Energy Metabolism--physiology Humans Ligands Lipid Metabolism--physiology Metabolic Syndrome--drug therapy Peroxisome Proliferator-Activated Receptors--agonists